Formulation and Drug Delivery

Taking an Alternative Approach to Drug Delivery

November 03, 2021

Alternative drug delivery approaches are promising, but due to their complexity, they need to be sufficiently justified.

Crystec, Biosidus Collaborate on Enhanced Delivery and Performance of Biotherapeutics

October 22, 2021

Crystec and Biosidus have joined forces to enhance the delivery and performance of biotherapeutics.

Considering Bio/Pharma Reformulation Strategies

October 03, 2021

Reformulation strategies are useful tools for more than just stretching out the potential return on investment for a product.

Getting a Nose for Vaccines

September 03, 2021

The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.

Enhanced Bioavailability of Acalabrutinib ASD Tablets In-Vivo

August 31, 2021

The pH effect encountered with oral oncology medication can be overcome with amorphous solid dispersions.

Syngene Announces Senior Level Appointments

August 06, 2021

Syngene International appoints two US-based executives to senior level positions.

Putting the Patient at the Heart of Dosage Form Design

August 03, 2021

Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.

In-Vivo Demonstration of Enhanced Bioavailability of Acalabrutinib ASD Tablets

August 03, 2021

Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.

Recent Research on Amorphous Solid Dispersions

August 02, 2021

Recent research has highlighted the underlying mechanisms of amorphous solid dispersions and theory behind the formation of drug-rich phases.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

July 12, 2021

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.